An observational study in Urinary Tract Disease, Cystitis and Antibiotic Reaction, sponsored by Kırklareli University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-03-02.
Sponsored by Kırklareli University · Observational
In this study, we will try to emphasize the effects of using cranberry tablets, which is an alternative to antibiotic therapy, during uncomplicated urinary tract infections (only urinary tract, bladder and kidney infections did not).
This study was Istanbul Kartal Dr. Lütfi Kırdar Training and Research Hospital Emergency Medicine Clinic and Kırklareli Training and Research Hospital Emergency Service and Internal Medicine Polyclinic. Our study; includes patients who applied to the Emergency Department and Internal Medicine outpatient clinic with the complaint of dysuria and had normal WBC, CRP, urea, and creatinine values in their analysis, and leukocyturia was found in the urine test. Two options were offered in the treatment to these patients. Vaccinium Macrocarpon Aiton preparation or fosfomycin was given for seven days. The patients were asked whether their complaints had decreased according to the Lykert-Type verbal scale at the time of admission and on the first, third, and seventh days. When the treatment was finished, leukocytes were checked in the urinalysis. This outcome was compared between the 2 treatment options. We also noted whether nausea.
197 studies on the registry are indexed under Urologic Diseases; 49 are open to participants now.
This study's enrollment of 2 is below the median of 200 across 50 observational studies indexed under Urologic Diseases.
Browse Urologic Diseases studies →Kırklareli University is the lead sponsor of 49 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Among the patients who were eligible criteria, the study was terminated when the number of patients in both groups reached 80.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The patients in this group; have been prescribed fosfomycin for 7 days (3 doses, two days apart).
Drug: Fosfomycin
The patients in this group; took 7 days (1 tablet each day) of cranberry tablets.
Dietary Supplement: Cranberry
In this group with urinary tract inflammation; Fosfomycin was prescribed for 7 days (3 doses, 2 days apart). There are 80 patients in total.
Also known as: monurol
In this group with urinary tract inflammation; 7 days (used every day) cranberry tablet was given. There are 80 patients in total.
Treatment time
After 7 days of treatment, the 2 treatment options were compared with each other.
Time frame: 7 days
Plan to share: No — The data results of the patients will be described in the article.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kırklareli University